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PROFOUND changes in the endocrinology of the host result from the growth of
not only the so-called functional endocrine tumours but also from the progressive
growth of non-functional tumours. Begg and Stewart (1952) and Begg (1955)
observed atrophy of the testes, seminal vesicle and prostate of rats bearing the
Walker carcinoma. This atrophy could not be influenced by force-feediilg
designed to maintain carcass weight of the tumour-bearer (Begg, 11958). They
found, however, that the atrophy could be prevented by the exogenous adminis-
tration of serum gonadotrophin and suggested that :
"
. . . the presence of a
tumour produces a deficiency of gonadotrophic hormone in the rat ". These
observations have been confirmed and extended by Haddow, Horning and
Carlton Smith (1957), who found that testicular changes were not as consistent as
those reported previously and were restricted to an increase in number and lipid
content ofthe Sertoli cells. Marked hypertrophy of the adrenals was a consistent
finding, and in some cases was associated with hypertrophic changes in the pitui-
tarygland. Atrophy ofthe accessory sex organs could be reversedby testosterone
propionate, serumgonadotrophii-i orby the subcutaneous implantation ofpituitary
glands.
Nissim (1957) found that nitrofurazone, an anti-bacterial drug sometimes used
in infections ofthe urinary tract, when added to the diet of mice in concentrations
of 0-15-0-3 per cent resulted in atrophy of the spermatogeiiic epithelium of the
testes, interstitial cell hyperplasia, and hypertrophy of the seminal vesicle. The
effect was absent in hypophysectomized mice, and he suggested that the andro-
genic action may be a manifestation of hyperactivity of the pituitary due to the
release from a pituitary inhibiting factor normally liberated from the germ cells
of the testes. Castration cells in the pituitary-an indication of hyperactivity
of gonadotrophic basophils-have been reported by Nelson and Steinberger
(1952) following the administration offuradroxyl, a drug having a similar actioli
to that of nitrofurazone. The present work deals with some effects of i-iitro-
furazone in normal and tumour-bearing rats. Should nitrofurazone be shown
to have an androgenic action in the rat as it does in the mouse, it would then be
possible to employ the drug as a stimulus to endogenous pituitary gonadotrophin
secretion in tumour-bearing rats and prevent progressive atrophy of the accessory
sex organs.
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MATERIALS AND METHODS
Male albino rats from the colony at the Chester Beatty Research Institute
were used throughout. They were 11 weeks old at the beginning of the experi-
nient and weighed roughly 300 g. The animals were housed six to a cage and
fed a semi-synthetic diet and water ad libitum. The composition of the basic
diet used in these experiments is shown in Table 1. Nitrofurazone was added to
the dry diet in concentrations of 0-15 and 0-30 per cent, which represent the
concentrations found by Nissim (1957) to produce seminal vesicle and prostatic
hypertrophy in mice.
TABLEI.-Compo8ition of the Diet
Per cent
Constituent by weight
Wheat flour 68
- 6
Casein 11-5
Milk powder 8
- 0
Margarine. 3
- 3
Bemax 2- 5
Yeast 2 4
Cod liver oil 1- 6
Calcium carbonate 1- 3
Glaxo salt mixture 0- 8
The dry diet was mixed with sufficient water to make a dough-like paste which was then fed to
the animals ad libituni.
The Walker carcinoma 256 serially transplanted at this Institute, grows very
rapidly and within 14 days mayweigh in excess of 70 g. Accordingly, all animals
were sacrificed by an overdose of ether anaesthesia 13 days after the subcutaneous
implantation of the tumour. At necropsy the testes, prostate, seminal vesicle
and tumour wereweighed to the nearest 0.01 g. The seminal vesicle was stripped
of coagulating gland and ligated at its junction with the ductus deferens before
excision to prevent loss ofseminal fluid. All tissues were fixed in Bouin's solution,
embedded in paraffin, sectioned at 5 microns and stained with haematoxylin
and eosin.
RESULTS
(a) The effect ofnitrofurazonefeeding on the teste8 and acce-s-sory 8ex organ'sofnormal
male rats
Eighteen rats of the same age and approximate weight were used for this
experiment. Six were fed the normal basic diet and acted as controls ; the
remaining 12 were divided into two groups receiving the basic diet supplemented
with nitrofurazone 0-15 per cent in one, and 0-50 per cent in the other. The
latter dose had to be reduced to 0-30 per cent after three days due to the death of
one rat and general physiological deterioration of the remaining five. After 25
days the experiment was terminated. The weights of the testes, seminal vesicle
and prostate are shown in Table 11. Nitrofurazonefeeding resulted in an appreci-
able loss of body weight in both groups of experimental animals ; the greater
weight loss was observed in those rats receiving the larger dose of the drug.
Although food consumptions were not recorded, daily observation of the animals
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dose ofnitrofurazone. In order to obviate the effects ofthe accompanyingweight
loss, the weights of the organs shown in Table 11 are expressed as a percentage of
of the body weight at death. Testicular atrophy was evident in all rats receiving
the drug but was greater in those fed the smaller dose ofthe drug. Histologically,
the testes showed profound degeneration of the spermatogenic epithelium (Fig.
la). Many tubules were filled with a faintly acidophilic, acellular, colloid or
mucoid substance. The same substance filled much of the interstitial spaces
normally occupied by Leydig tissue. However, hyperplasia of the interstitial
cells as described by Nissim (1957) in the mouse was not evident.
TABLEII.-The Effect ofNitrofurazone Feeding on Body Weight, Testes and
Accessory Sex Organs of -.,-Vormal Male Rats
Death Seminal
weight Testes vesicle Prostate
Number (g.) (mg./100 g. body weight)
Normal diet 6 522±21* 726±28 209±20 105 4-9
0 15% nitrofurazone in diet 6 366 10 377 ±27 349±48 120±10
(<0.001) (<0-001) (< 0
-02)
0 30% nitrofurazone in diet 5 307 +13 514±52 224+30 94±38
(<0.001) (<0.01)
Mean standard error.
) Statistical probability of difference from normal diet.
The mean absolute weight of the seminal vesicles in the group of rats fed the
lower dose of nitrofurazone was greater than that of the rats on the basic diet.
When expressed as a percentage of the body weight this increase (140 mg.) was
statistically significant at the P <0.02 level. The increase in proportionate
weight of the organ in the group of rats fed the higher dose of nitrofurazone was
less obvious. Histologically, the seminal vesicles of the experimental animals did
not differ from those of the normal rats. The weights and histology of the pros-
tates of the experimental animals were not unlike those of the controls.
(b) The effect of nitrofurazonefeeding on the te8te8 and accessory 8ex organs of rats
bearing the Walker carcinoma 256
Thirty I1-week-old rats of approximately the same weight received subcu-
taneous implants of the Walker carcinoma 256. Eighteen were given the basic
diet, and 12 the basic diet supplemented with 0- 15 per cent nitrofurazone ad
libitum. Twelve normal rats of the same age and weight fed the basic diet alone,
served as controls. Thirteen days after the implant all animals were sacrificed
by an overdose of ether anaesthesia. The weights of the tumours testes and
accessory sex organs at necropsy are shown in Table 111. Once again, the mean
weights are expressed as a percentage of the final body weight. Growth of the
Walker tumour had no notable effect on the gross weight of the testes when
compared with that of the non-tumour-bearing controls. However, atrophy of
the accessory sex organs of the tumour-bearers was a consistent finding. The
mean proportionate weight of the seminal vesicle was 44 per cent, and that of the
prostate 46 per cent lower than those of the normal rats. Haddow, Horning and
Carlton Smith (1957) have shown this atrophy to be roughly proportional to the
weight of the tumour. Fig. 2 shows the relationship between seminal vesicle.-N
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TABLE III.-The, Effect ofNitrofurazone on the Testes and
Accessory Sex Organs ofTumour-bearing Male Rats
Final Tumour weight
body weight (% body
Number (g.) weight)
Normal rats (basic diet)
. 12 492±14*
p <0. I
Tumour-bearers (basic diet) 18 413±19 13-8±1-9
p <0-01 <0-6
Tumour-bearers (0-15% nitro- 12 328±22 15-2±0-8
furazone in diet)
* Mean ± standard error.
Seminal
Testes vesicle Prostate
(mg./100 g. body weight)
786±23 218±13 122±9
<0-3 <0.01 <0-001
844±35 122±20 66+7
<0-001 <0-7 <0-8
461±10 110±14 71±9
-r=-0-664+0-117 (P<-001)
y
= 1-015-0-0094 x
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FiG. 2.-Relationship between theweight of the seminal vesicle and the weight of the tumour
in 24 rats bearing the Walker carcinoma 256.
weight and tumour weight in 24 untreated tumour-bearers (I8 from this experi-
ment and 6 from the experiment described in Section c). Although the scatter
is great, a statistically significant negative correlation (r -0-664 ± 0-117)
could be demonstrated between the two measurements. Roughly 43 per cent
of any decrease in seminal vesicle weight is associated with an increase in tumour
weight.
The feeding of nitrofurazone to tumour-bearing rats resulted in body weight
loss and profound testicular degeneration similar to that observed in normal
rats (Section a), but had no effect on the seminal vesicle and prostatic atrophy
associated with the growing tumour. The drug had no notable effect on the rate
ofgrowth of the tumour.
(e) The effect ofnitrofurazone administered intraperitoneally
Six tumour-bearing rats were treated daily with 10 mg. of nitrofurazone
suspended in 0-4 ml. ofarachis oil. Six untreated tumour-bearers and six normal323 EFFECT OF NITROFURAZONE
rats acted as controls. Injections were started on the second day after implanta-
tion of the tumour and were continued for 10 days. The results of this experi-
ment are seen in Table IV. As expected, growth of the Walker tumour resulted
TABLEIV.-The Effect ofNitrofurazone Admini,3tered Intraperitoneally
on the Teste8 and Acce88ory Sex Organ8 ofTumour-bearing Rat8
Final Tumour weight Seminal
body weight (% body Testes vesicle Prostate
Number (g.) weight) (mg./ 100 g. body weight)
Normal rats 6 361±14* 1085±41 178±11 92±7
p <0.2 <0.01 <0.001 <0.02
Untreated tumour-bearers 6 403 +21 17
-4±1- 2 845±59 60±14 54±11
p <0.9 <0.5 <0.9 <0.01 <0-5
Tumour-bearers (10 mg. nitro-6 406±9 14- 2±2 0 889±51 124+8 64±4
furazone daily for 10 days)
* Mean -.- standard error.
in marked seminal vesicle and prostatic atrophy. The epithelial lining of the
seminal vesicle was altered from the high columnar type to a low cuboidal non-
secretory type (Fig. 3a). There was a decrease in seminal fluid and an increase in
the fibromuscular stroma ofthegland. Atrophy ofthe testes was more noticeable
than in the previous experiment ; however, sections of the testes stained with
haematoxylin and eosin revealed no obvious alteration in testicular structure.
Haddow, Horning and Carlton Smith (1957) have shown that Sudan IV staining
of frozen sections of the testes reveals an increase in number and lipid content of
the Sertoli cells in the tumour-bearer, which was taken as evidence of some
abnormality in testicular function.
Treatment with 10 mg. of nitrofurazone daily for 10 days had no effect on
body weight nor on the weight of the tumour at necropsy when compared with
the untreated tumour-bearers. Nor were the testes of the treated group of rats
different from those of the untreated tumour-bearers in gross weight and in
histological appearance. In fact, the only notable effect ofthis treatment was the
almost complete restoration of the weight and histological appearance of the
seminal vesicle to that seen in normal male rats ofthe same age (Fig. 3b). Changes
in the weight and histology of the prostate were less obvious. Thus the atrophic
changes in the seminal vesicle and to a lesser degree in the prostate, can be largely
prevented by the intraperitoneal administration of nitrofurazone.
Larger doses of nitrofurazone (30 mg./day for four days) proved fatal to two
out of six tumour-bearers. The remaining four showed, at autopsy, profound
testicular atrophy, while the seminal vesicles were slightly but not significantly
larger than those of the untreated tumour-bearers. The body weights and
tumour weights of these four treated animals did not differ from those of the
untreated group.
DISCUSSION
There appears to be a growing belief among clinicians and experimentalists
that the progressive growth of tumours has widespread constitutional effects on
the host-depression ofliver catalase activity,hypertrophy ofadrenal andpituitary glands, atrophy of the-gonads and accessory sex organs, and ultimately malignant324 D. G. MONTEMURRO
eachexia, to mention but a few. The results of the present work confirm the
previously-made observations of Begg (1955), Begg and Stewart (1952) and of
Haddow, Horning and Carlton Smith (1957) that the growth of the Walker rat
careiiioma 256 results in atrophic changes in the seminal vesicle andprostate, and
to a less notable extent in the testes. Microscopically the accessory sex organs
present a picture ofgrossly diminished or complete absence ofsecretion, reduction
in the height of the cells of the secretory epithelium and an increase in fibro-
muscular stroma. These changes can be prevented or reversed by the exogenous
administration of serum gonadotrophin (Begg, 1955), testosterone propionate,
or by the implantation of fresh pituitary glands (Haddow et al., 1957). The
results of the present study show that a protective action against these changes is
provided by the daily administration of nitrofurazone (Table INT and Fig. 3b).
The androgenic action of nitrofurazone shown by Nissim (1957) to be present
in the mouse may also be obtained in the rat. Both speciesrespond to treatment
with profound degenerative changes in the spermatogenic epithelium of the
seminiferous tubules, but hypertrophy of the accessory sex organs is less dramatic
than that described in the mouse. The reason for this difference may be that
degeneration ofthespermatogenicepithelium in the rat testes was notaccompanied
by any noticeable hyperplasia of the interstitial tissue. Hyperplasia of Leydig-
cell tissue was more apparent than real, due to the large interstitial spaces left
by the shrunken and distorted atrophic tubules (Fig. la). Further, mitotic
figures were not more numerous in the interstitial tissue of nitrofurazone-treated
rats than in that of untreated normal rats.
The results of these experiments allow some comment on the possible
mechanism of the androgenic action of nitrofurazone. Nissim (1957) suggested
that this action is attributable to increased pituitary gonadotrophin activity
consequent on the withdrawal of an
" inhibitory substance
" normally liberated
by the intact seminiferous tubules. In the experiments on the rat reported here,
the maximum hypertrophy of the seminal vesicle-or, more accurately, the
greatest inhibition of seminal vesicle atrophy-was seen in those rats that did
not show degenerative changes in the spermatogenic epithelium (Table IV).
This would indicate that the postulated increase in pituitary gonadotrophin
activity following treatment with nitrofurazone is not necessarily dependent on
initial degeneration of the spermatogenic epithelium of the testes.
An adequate explanation for the failure of nitrofurazone feeding to prevent
atrophy of the accessory sex organs of the rats shown in Table III is wanting
However, since administration of the drug by the intraperitoneal route did not
produce anorexia and weight loss, the severe under-nutrition associated with the
feeding experiments may have resulted in a pituitary gland refractory to any
stimulatory action of the drug. Mulinos and Pomerantz (1940) have compared
the hormonal imbalances of malnutrition to that of surgical hypophvsectomy
and described this pheiiomenon as a dietary pseudo-hypophysectomy.
Some degree of nutritional deficiency or metabolic alteration probably plays a
niajor role on the atrophic changes seen in the accessory sex organs and to a
lesser extent in the gonads associated with the progressive growth of a tumour.
Hormotial imbalances may be effected by retention ofgonadotrophic hormone by
the pituitary basophils in a similar manner to that described by Rinaldini (1949)
and Pearse and Rinaldini (1950) in semi-starved rats. Experiments to assess the
gonadotrophic content of the pituitary gland of tumour-bearing rats employingEFFECT OF NITROFURAZONE 325
bioassay and cytochemical techniques will shortly be in progress. It is hoped
that these experiments will provide a better understanding of the role of the
pituitary and hormone homeostasis in the widespread constitutional changes
seen in tumour-bearing animals.
SUMMARY
1. The effect of nitrofurazone on the testes, seminal vesicle and prostate of
normal rats and rats bearing the Walker carcinoma 256 were studied.
2. Nitrofurazone added to the diet ofnormal adult male rats in a concentration
of 015 per cent resulted in body weight loss, profound degeneration of the
spermatogenic epithelium of the testes and a slight hypertrophy of the seminal
vesicle. Hyperplasia of interstitial testicular tissue was not apparent.
3. Atrophic changes in the seminal vesicle consisting of a reduction in height
of the secretory epithelial cells, a reduction in the amount of seminal secretion,
and a notable increase in fibro-muscular stroma of the gland were associated with
growth ofthe Walker tumour. The degree of atrophy was significantly correlated
with the weight of the tumour.
4. Addition of nitrofurazone to the diet of tumour-bearing rats failed to
prevent atrophy of the seminal vesicle and prostate glands. Degeneration of
the spermatogenic epithelium of the testes was similar to that seen in normal rats.
5. Intraperitoneal administration of 10 mg. of nitrofurazone for 10 days
protected tumour-bearing rats against atrophy of the accessory sex organs.
This protection was associated with no abnormal change in body weight, nor in
weight or histological appearance of the testes.
6. These findings are compared with the previously reported effects of nitro-
furazone in the mouse. It is suggested that cytological studies of the pituitary
gland of tumour-bearing rats would provide a clearer understanding of the
hormonal imbalances associated with the growth of tumours.
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EXPLANATION OF PLATE
FIG. la.-Testes of a rat fed nitrofurazone 0-15 per cent in the diet for 25 days. Note
degeneration of the spermatogenic epithelium and the mucoid substance filling many of the
spaces between distorted tubules. Hyperplasia of interstitial tissue is not apparent.
x 23.
FIG. lb.-Testes of a normal rate. x 23.
FIG. 3a.-Atrophic seminal vesicle of a tumour-bearing rat. Note decrease in seminal fluid
and increase in fibro-muscular stroma. x 7.
FIG. 3b.-Seminal vesicle of tumour-bearing rat treated daily for 10 days with 10 mg. of
nitrofurazone intraperitoneally. The relative amounts of seminal secretion and fibro-
muscular stroma resemble that of a normal gland. x 7.Vol. X.IV,, No. 2. BRITISII JOURNAL OF CANCER.
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